Defective Breast Mesh, Acellular Dermal Matrix, and Bioabsorbable Scaffold Injury Attorneys in Iowa: The Complete Guide for Women, Families, and Survivors
For women in Iowa who have undergone breast reconstruction after a mastectomy, or those who sought aesthetic improvement through breast augmentation or a lift, the decision was about more than just surgery. It was about restoration, health, and a return to a sense of self. You trusted that the medical devices placed in your body—the surgical meshes, the acellular dermal matrices (ADM), and the bioabsorbable scaffolds—had been rigorously tested, approved, and proven safe for use in human breast tissue.
However, a growing body of evidence, regulatory warnings from the FDA, and whistleblower testimony suggest that many of these products were never properly vetted for breast surgery. Whether you received your care at the Holden Comprehensive Cancer Center in Iowa City, a regional surgical hub in Des Moines, or a private plastic surgery practice in Cedar Rapids, the reality remains the same: thousands of women in Iowa were implanted with devices that the FDA now explicitly warns have “not been determined” to be safe or effective for breast applications.
We understand the fear and betrayal you may feel if you are currently battling an infection that won’t clear, facing a diagnosis of a rare lymphoma like BIA-ALCL, or dealing with the physical and emotional toll of multiple revision surgeries. At Attorney911, led by Ralph Manginello and Lupe Peña, we represent women in Iowa who have been victimized by defective medical devices. We possess the technical command of FDA regulations and the litigation strength necessary to take on the multi-billion-dollar manufacturers who prioritized market share over patient safety.
If you are suffering from complications related to breast mesh, ADM, or a scaffold like GalaFLEX or Phasix, you are not alone in Iowa. This guide is designed to provide you and your family with the medical, regulatory, and legal answers you need to protect your health and your future.
Understanding the Devices: Mesh, ADM, and Scaffolds in Iowa Breast Surgery
To handle a legal claim in Iowa, it is essential first to understand exactly what was placed in your body. In both reconstructive and cosmetic surgeries, surgeons often use “internal bras” or support structures to hold an implant in place, create a more natural shape, or reinforce weakened tissue. These products generally fall into three categories:
1. Acellular Dermal Matrix (ADM)
ADM is a biologic material derived from donated human or animal skin (porcine/pig or bovine/cow). The “acellular” part means the manufacturer has stripped the donor’s cells away, leaving behind a “scaffolding” of collagen. Products like AlloDerm (Allergan/AbbVie), FlexHD (MTF Biologics), and Strattice are widely used in Iowa. While they are meant to be incorporated into your own tissue, they have been linked to high rates of “Red Breast Syndrome” and deep surgical site infections.
2. Bioabsorbable Scaffolds
These are synthetic, man-made materials designed to be absorbed by your body over 12 to 24 months. The most prominent example used in Iowa is GalaFLEX, made from a material called poly-4-hydroxybutyrate (P4HB). The manufacturer markets these as being “stronger than silk,” but many women find that the scaffold does not dissolve as promised, remains palpable, and causes chronic, debilitating pain or inflammation.
3. Synthetic Surgical Mesh
Standard synthetic mesh (like polypropylene) is sometimes used in breast surgery, though this is purely “off-label.” These permanent meshes are known for “shrinking,” migrating, or eroding through the skin, causing permanent disfigurement.
If you are unsure which device was used during your procedure at a facility like UnityPoint Health or MercyOne, our team can help you secure your operative reports and identify the specific brand—the first step in holding the right manufacturer accountable.
The FDA Regulatory Failure: What Iowa Patients Weren’t Told
One of the most shocking aspects of the breast mesh litigation is the regulatory pathway these devices used to enter onto the market. Most medical devices used in Iowa hospitals are cleared through the FDA’s 510(k) clearance pathway (under 21 CFR Part 807 Subpart E).
Under this pathway, a manufacturer does not have to prove their device is safe and effective through clinical trials. Instead, they only have to show it is “substantially equivalent” to a “predicate device” already on the market. In a phenomenon known as “predicate creep,” modern bioabsorbable meshes used in breast surgery were cleared by claiming they were similar to general surgical sutures or hernia meshes.
For years, manufacturers marketed these products to Iowa surgeons for use in breast reconstruction, despite the fact that the FDA had never approved them for that specific anatomical site. On November 9, 2023, the FDA issued a landmark letter to healthcare providers, explicitly stating: “The safety and effectiveness of surgical mesh in breast surgery, including in augmentation or reconstruction, has not been determined by the FDA.”
For a woman in Iowa who was told her reconstruction was “standard of care,” learning that the mesh used was essentially an unproven experiment is devastating. At Attorney911, we use this regulatory history to overcome the “Learned Intermediary Doctrine,” arguing that the manufacturers failed to warn both the patient and her Iowa surgeon about the inherent risks of these unapproved uses.
The Spectrum of Complications: From Infection to ALCL
The complications arising from these devices are not mere “side effects.” They are often catastrophic injuries that require multiple follow-up surgeries, long-term IV antibiotics, and in the worst cases, the total loss of the reconstruction.
Red Breast Syndrome (RBS) and Endotoxin Science
Many Iowa ADM patients experience a persistent, non-infectious redness known as Red Breast Syndrome. While surgeons often treat this with antibiotics, the science points to a different cause: bacterial endotoxins. Even after terminal sterilization, fragments of gram-negative bacterial cell walls (lipopolysaccharides) can remain on the ADM. When implanted, these endotoxins trigger a chronic inflammatory response in the breast tissue. This is a manufacturing defect, and we hold manufacturers like MTF Biologics accountable for selling “sterile” products that still carry harmful endotoxin loads.
BIA-ALCL and BIA-SCC: The Cancer Connection
Beyond surgical complications, certain devices—specifically textured breast implants like the Allergan BIOCELL and adjacent mesh products—have been linked to Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL). This is a rare T-cell lymphoma that develops in the scar capsule.
Furthermore, the FDA has identified an emerging risk of Breast Implant-Associated Squamous Cell Carcinoma (BIA-SCC). If you have experienced late-onset swelling or a lump years after your surgery in Iowa, you require immediate biopsy and CD30-positive/ALK-negative testing to rule out these malignancies.
Scaffold Resorption Failure
For patients who received GalaFLEX or Phasix in Iowa, the primary failure mode is often mechanical. The scaffold is supposed to dissolve, but many patients report it remains present or becomes hard (fibrosis), leading to “animation deformity” (the breast moving unnaturally with muscle contraction) or permanent neuropathic pain.
Iowa Product Liability Law and Your Right to Compensation
Filing a lawsuit in Iowa requires a deep understanding of the Iowa Code § 614.1, which sets the statute of limitations for personal injury and product liability claims. Typically, you have two years from the date of the injury to file a lawsuit.
However, the “Discovery Rule” is critical in medical device cases. For many women in Iowa, the two-year clock may only begin once they discovered—or reasonably should have discovered—that their complications were caused by the mesh or scaffold. This discovery often happens after a second opinion or after reading an FDA safety communication.
Iowa also follows a Comparative Fault model under Iowa Code § 668.3. This means that even if the defense tries to argue that surgical technique or patient health contributed to the outcome, you can still recover damages as long as your fault is not greater than the combined fault of the defendants.
Our firm works to secure comprehensive damages for Iowa survivors, including:
- Economic Damages: Coverage for past and future medical bills, including the cost of explant surgery and reconstruction salvage (such as DIEP flap procedures).
- Lost Wages: Compensation for time taken off work during lengthy recoveries.
- Non-Economic Damages: Recognition for the pain, suffering, emotional distress, and permanent disfigurement caused by a failed reconstruction or a cancer diagnosis.
Why Experience Matters: The Attorney911 Difference in Iowa
Medical device litigation is not a job for a generalist. It requires an attorney who can speak the language of pathology and federal regulation.
Ralph P. Manginello has been licensed since 1998 (Bar Card No. 24007597) and is admitted to the United States District Court for the Southern District of Texas. Together with Lupe Peña (Bar Card No. 24084332), our firm has established a reputation for prosecuting high-profile, multi-defendant institutional liability cases. A prime example is our current leadership in Bermudez v. Pi Kappa Phi, where we are seeking $10,000,000 in damages against thirteen defendants in complex litigation.
We bring that same “aggressive resourcefulness” to breast mesh cases. We don’t just rely on what the manufacturers say; we look at the MAUDE database (Manufacturer and User Facility Device Experience) to find the adverse event reports they tried to hide. We also draw on the record of whistleblowers like Dr. Hooman Noorchashm, the former BD Medical Director who alleges that the company withheld data regarding breast cancer recurrences in GalaFLEX trials.
Additionally, for our Spanish-speaking community members in Iowa, Hablamos español. Lupe Peña conducts full consultations in Spanish, ensuring that nothing is lost in translation when discussing your medical history and legal rights.
The Allergan BIOCELL MDL 2921 and Current State of Litigation
Many of our Iowa clients are part of the Allergan BIOCELL MDL 2921, currently centralized in the District of New Jersey before Judge Brian R. Martinotti. This multi-district litigation (MDL) handles thousands of claims related to the 2019 recall of textured implants. The first bellwether trials are currently scheduled for October 19, 2026.
For those with GalaFLEX or Phasix injuries, cases are currently moving forward in state-court coordinated proceedings, such as those in Rhode Island, where the defendants Becton, Dickinson and Company (BD) maintain their surgical mesh headquarters. We stay at the forefront of these developments to ensure your Iowa-based claim is positioned for maximum recovery.
Frequently Asked Questions for Iowa Patients
What if my surgeon in Des Moines told me the mesh was safe?
Surgeons are often the victims of manufactured misinformation. If the manufacturer’s sales representative sat in the operating room or provided biased training that downplayed the risks, the liability rests with the manufacturer, not the surgeon.
How do I find out the brand of mesh I have?
You should request your full “operative report” and “implant log” from the hospital where you had your surgery. These records contain the Unique Device Identifier (UDI) and lot numbers for every device used. If you have trouble getting these, we can handle the records request for you.
Can I sue even if I didn’t get cancer?
Yes. Most of our cases involve surgical site infections, reconstruction failure, and permanent disfigurement. You do not need a cancer diagnosis (BIA-ALCL) to pursue a product liability claim for a defective mesh or scaffold.
What is the cost of a consultation?
We work on a contingency-fee basis. This means there are no upfront costs to you, and we only get paid if we successfully recover compensation for you. Our goal is to provide Iowa women with the access to justice they deserve without financial burden.
How long do these cases take?
Medical device litigation is a marathon, not a sprint. Because these cases involve complex scientific evidence, they often take several years to reach a resolution or a settlement matrix. We provide you with regular updates so you always know where your case stands.
Immediate Steps to Protect Your Health and Legal Rights
If you are a woman in Iowa experiencing complications from breast surgery, we recommend the following:
- Seek a Second Medical Opinion: If your original surgeon is dismissive of your pain or redness, consult with a breast reconstruction specialist at a different institution, such as the University of Iowa Hospitals and Clinics, to get an objective assessment.
- Request Your Medical Records: Specifically, ask for your operative reports and pathology slides if you have had tissue removed.
- Document Your Symptoms: Keep a journal of your pain, take photographs of any visible changes in the breast, and track all follow-up appointments.
- Preserve the Explanted Device: If you are undergoing surgery to remove the mesh, scaffold, or implant, notify your surgeon and the hospital pathology lab that you want the device preserved as evidence. Do not let the manufacturer “take the device for testing.”
- Speak with a Specialized Attorney: Contact Attorney911 at 1-888-ATTY-911 for a free, confidential case evaluation.
Contact Attorney911 Today
At The Manginello Law Firm, PLLC, we believe that when a manufacturer places an unproven, defective device in a woman’s body, they are responsible for every surgery and every moment of pain that follows. We represent the survivors—the women throughout Iowa who are standing up to these corporations to ensure this doesn’t happen to anyone else.
Ralph Manginello and Lupe Peña are ready to hear your story. Whether you are in Iowa City, Des Moines, Ames, Davenport, or Sioux City, we can help you work through the complications and fight for the compensation you need to move forward.
Call 1-888-ATTY-911 (1-888-288-9911) today. Your health matters. Your restoration matters. We are here to listen.
Hablamos español. Consulta gratuita. No cobramos si no ganamos.
Disclaimer: This page is for educational purposes and does not constitute legal advice. Past results, such as the multi-million-dollar recoveries mentioned, do not guarantee future outcomes. Contacting the firm does not establish an attorney-client relationship. Attorney911 is a consumer brand of The Manginello Law Firm, PLLC. Our principal office is located in Houston, Texas, and we represent clients in federal courts and through local counsel associations nationwide where permitted.
